DonCorleone77
Posted - 1 day ago
$MACK Merrimack receives $225M milestone payment from Ipsen Merrimack Pharmaceuticals (MACK) announced that it has received a $225M payment which was due from Ipsen (IPSEY) as a result of its receipt of approval from the U.S. Food and Drug Administration, or FDA, to market ONIVYDE as a first-line treatment of metastatic adenocarcinoma on the pancreas. Merrimack's Board of Directors has evaluated the likelihood of receiving additional milestone payments under the Ipsen Agreement and from the 2019 Agreement with Elevation Oncology and has concluded that it is unlikely that any additional milestone payments from either agreement will become payable. We have announced a special meeting of stockholders on May 10, 2024 to approve a Plan of Dissolution which includes plans for a liquidating dividend payable to stockholders. We currently anticipate the initial liquidating dividend to be in the range of between approximately $14.68 and $15.30 per share....
Stock_Titan
Posted - 1 day ago
$MACK Merrimack Receives $225 Million Milestone Payment from Ipsen
https://www.stocktitan.net/news/MACK/merrimack-receives-225-million-milestone-payment-from-kemtwncrd43g.html
Oncourtking127
Posted - 2 weeks ago
$MACK 👀
Stock_Titan
Posted - 3 weeks ago
$MACK Merrimack Reports Full Year 2023 Financial Results
https://www.stocktitan.net/news/MACK/merrimack-reports-full-year-2023-financial-tsbta38t8udc.html
Bornjever
Posted - 1 month ago
$MACK so the date is unknown so we must keep our position??? Is there any idea on what dividend per person is?? Would really help me as I got my little money I have tied up in this position and need to use in March. Thank You
gradcash
Posted - 1 month ago
$MACK so, when will news come out that Mack has received the 225M? EOM? i hope they money market it
Telefon
Posted - 1 month ago
$ELTP Elite Pharmaceuticals has reported outstanding revenue and profits the last three quarters. They just reported a 67% increase in revenue and a 52% increase in operating profits the third quarter compared to the same period last year. This low debt generic pharmaceutical company trades on the OTC, and the share priced has almost quadrupled since August of last year. The company is in the process of expanding manufacturing and storage capacity to meet the unprecedented demand for Adderall as a result of a nationwide shortage. The CEO's goal is a buyout within two years. Invest in ELTP, the Jewel of the OTC! $MACK $FGEN $INGN $CRBP
IronPatriot1001
Posted - 1 month ago
$IOVA Keeping things in perspective, $MACK received approval right at the deadline. The FDA must be very behind if they are issuing approvals on the last possible day. Leads me to believe an approval statement will be issued next week. Impatient swing traders are dumping today. Their loss is your gain.
This_Bull_Is_Retired
Posted - 1 month ago
$MACK Ask yourself why would they be shoring up the balancesheet if there wasn't some other path they were taking. The company is ceasing future development efforts on AUR200 and its pre-clinical asset AUR300. Correspondingly, the company expects to take a restructuring charge of approximately $11M-$15M in 1Q24. The company anticipates reducing employee headcount by at least 25% by the end of 1Q24. There is no planned reduction in headcount in commercial or commercial supporting roles.
RunningRobert1
Posted - 1 month ago
$MACK Merrimack Pharmaceuticals MACK Approval Summary 14Feb2024 https://youtu.be/1hZm_4Bm4Bg A summary about approval and what it means for the stock, also talking about future milestones and the future of the company!
shared_alerts
Posted - 1 month ago
-02/14/2024-
📉 SCANNER UPDATE📈 $HEPA $BYCY $CNK $MACK ↩️
IronPatriot1001
Posted - 1 month ago
$IOVA $MACK jumped on approval. So have several others. The question is ... will you sell after approval? Major institutions are in for the long term, when this stock will hit $40+. If the opportunity cost is too high, then sell for modest gains
justforstocks
Posted - 1 month ago
$MACK why couldn't they schedule the meeting in April instead of May? I want to close this position and move on. If IPSEN pays the dividend in March, then there is no reason why it can't be liquidated by April... ugh
Moneyguru95
Posted - 1 month ago
$MACK grabbed some $16C expiring this week incase this gets some movement in the coming days
kingscats
Posted - 1 month ago
$MACK Well if they think they can dissolve for $16/ share and forego the remaining ~$200m of milestone payments - get ready for a class action lawsuit!
1LIFE2LIVE
Posted - 1 month ago
$MACK “$14.65 - $15.35 per share - close down the Company and liquidating the trust.” 🍻
DosGatos
Posted - 1 month ago
$MACK Mercifully coming to an end!!
lanokota
Posted - 1 month ago
$MACK Great time for a press release - not! When fab news might barely move the needle. Try 8am! Sheesh!
makku
Posted - 1 month ago
$MACK soon this week
1LIFE2LIVE
Posted - 1 month ago
$MACK Based on the information currently available, Merrimack management estimates that the aggregate amount of the liquidating dividend payable to stockholders will be in the range of between approximately $14.65 and $15.35 per share. These estimates are based on, among other things, the receipt of the $225M milestone from Ipsen, Merrimack’s current and projected balance of cash, cash equivalents and marketable securities, estimated federal and state taxes payable for 2024, interest payable to the federal government pursuant to Internal Revenue Code Section 453A and state governments pursuant to similar state tax provisions due on the receipt of the Ipsen milestone payment, proceeds from the expected exercise of stock options, and amounts that will need to be retained by the Company to fund close down expenses and the liquidating trust.
Stock_Titan
Posted - 1 month ago
$MACK Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
https://www.stocktitan.net/news/MACK/merrimack-reports-ipsen-announcement-of-approval-by-the-us-fda-of-ea26vf4odax7.html
Green_Rock
Posted - 1 month ago
$MACK damn! red day ruined this.
OpenOutcrier
Posted - 1 month ago
RECAP 2/13 Chatter: $MACK + Onivyde Approval $GH + Channel Checks $VZIO + $WMT Live Breaking trading news www.openoutcrier.com
kingscats
Posted - 1 month ago
$MACK CONGRATULATION TO ALL LONGS HERE! Let’s collect our $225M in milestone payments now and the rest later ! $SPY $QQQ
kingscats
Posted - 1 month ago
You should sell now and let us old timers stay here to collect the rest of the milestone payments - you got ur $15+ price ,now time for u to take ur negativity to some other bio stock! $MACK @This_Bull_Is_Retired
makku
Posted - 1 month ago
$MACK Divident will be 31 this will be 20 tomorrow!
justforstocks
Posted - 1 month ago
$MACK For those who know the ins and outs- what is the best option here? Sell all shares with the spike or wait for the dividend? Thank you
1LIFE2LIVE
Posted - 1 month ago
$MACK There are $31.95 (give or take) in potential milestone dividend’s payable to MACK shareholders by Ispen. Ispen has to pay out starting with this 1st $225M, etc - they will do that or more than likely acquire them for a bit less. Patience here has paid off and will continue to do so.
FBP
Posted - 1 month ago
$MACK what a heroic long for those who held since the deal many years ago. I don’t have those diamond hand but kudos to you all